U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07071623) titled 'A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)' on July 08.
Brief Summary: Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection.
The goals of this study are to learn:
* If taking MK-8527 once a month works to prevent HIV-1 infection better than a standard (usual) pre-exposure prophylaxis (PrEP) taken once a day
* About the safety of MK-8527 and if people tolerate it
Study Start Date: Oct. 31, 2025
Study Type: INTERVENTIONAL
Condition:
Human Immunodeficiency Virus (HIV)
HIV Pre-Exposure Prophylaxis
Intervention:
DRUG: MK-8527
Oral...